News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
737,074 Results
Type
Article (42643)
Company Profile (270)
Press Release (694143)
Multimedia
Podcasts (99)
Webinars (22)
Section
Business (206009)
Career Advice (2059)
Deals (35760)
Drug Delivery (133)
Drug Development (82072)
Employer Resources (173)
FDA (16631)
Job Trends (15112)
News (348962)
Policy (33128)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2637)
Accelerated approval (48)
Adcomms (28)
Allergies (172)
Alliances (49996)
ALS (212)
Alzheimer's disease (1815)
Antibody-drug conjugate (ADC) (466)
Approvals (17019)
Artificial intelligence (679)
Autoimmune disease (296)
Automation (56)
Bankruptcy (371)
Best Places to Work (11727)
BIOSECURE Act (20)
Biosimilars (224)
Biotechnology (175)
Bladder cancer (198)
Brain cancer (72)
Breast cancer (763)
Cancer (5910)
Cardiovascular disease (481)
Career advice (1753)
Career pathing (43)
CAR-T (335)
CDC (60)
Celiac Disease (3)
Cell therapy (915)
Cervical cancer (47)
Clinical research (71244)
Collaboration (2089)
Company closure (5)
Compensation (1410)
Complete response letters (82)
COVID-19 (2871)
CRISPR (108)
C-suite (1148)
Cystic fibrosis (152)
Data (8026)
Decentralized trials (3)
Denatured (32)
Depression (164)
Dermatology (88)
Diabetes (591)
Diagnostics (6997)
Digital health (55)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (325)
Drug pricing (203)
Drug shortages (31)
Duchenne muscular dystrophy (287)
Earnings (92258)
Editorial (67)
Employer branding (21)
Employer resources (152)
Events (120603)
Executive appointments (1092)
FDA (20394)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (18)
Frontotemporal dementia (35)
Funding (1750)
Gene editing (236)
Generative AI (56)
Gene therapy (729)
GLP-1 (1071)
Government (4850)
Grass and pollen (6)
Guidances (408)
Healthcare (19236)
HIV (81)
Huntington's disease (56)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (98)
Immunology and inflammation (293)
Immuno-oncology (95)
Indications (196)
Infectious disease (3221)
Inflammatory bowel disease (218)
Inflation Reduction Act (14)
Influenza (140)
Intellectual property (294)
Interviews (326)
IPO (16701)
IRA (50)
Job creations (3683)
Job search strategy (1451)
JPM (61)
Kidney cancer (19)
Labor market (103)
Layoffs (569)
Leadership (42)
Legal (8015)
Liver cancer (100)
Longevity (33)
Lung cancer (781)
Lymphoma (433)
Machine learning (60)
Management (59)
Manufacturing (1064)
MASH (192)
Medical device (14034)
Medtech (14163)
Mergers & acquisitions (20306)
Metabolic disorders (1522)
mRNA (218)
Multiple sclerosis (190)
NASH (17)
Neurodegenerative disease (426)
Neuropsychiatric disorders (106)
Neuroscience (3344)
Neurotech (1)
NextGen: Class of 2026 (6582)
Non-profit (4604)
Now hiring (78)
Obesity (712)
Opinion (300)
Ovarian cancer (226)
Pain (260)
Pancreatic cancer (310)
Parkinson's disease (366)
Partnered (33)
Patents (600)
Patient recruitment (678)
Peanut (63)
People (60094)
Pharmaceutical (59)
Pharmacy benefit managers (32)
Phase 1 (22215)
Phase 2 (31367)
Phase 3 (23374)
Pipeline (8931)
Policy (325)
Postmarket research (2582)
Preclinical (9483)
Press Release (65)
Prostate cancer (309)
Psychedelics (55)
Radiopharmaceuticals (330)
Rare diseases (1089)
Real estate (6021)
Recruiting (70)
Regulatory (25690)
Reports (56)
Research institute (2442)
Resumes & cover letters (356)
Rett syndrome (39)
RNA editing (23)
RSV (89)
Schizophrenia (181)
Series A (292)
Series B (215)
Service/supplier (11)
Sickle cell disease (113)
Special edition (25)
Spinal muscular atrophy (168)
Sponsored (50)
Startups (3690)
State (2)
Stomach cancer (18)
Supply chain (128)
Tariffs (87)
The Weekly (65)
Vaccines (1141)
Venture capital (115)
Weight loss (461)
Women's health (128)
Worklife (20)
Date
Last 7 days (680)
Last 30 days (3360)
Last 365 days (30206)
2026 (13161)
2025 (30331)
2024 (35392)
2023 (40251)
2022 (51404)
2021 (56005)
2020 (54589)
2019 (46914)
2018 (35356)
2017 (32313)
2016 (31767)
2015 (37802)
2014 (31593)
2013 (26642)
2012 (28859)
2011 (29529)
2010 (27636)
Location
Africa (771)
Alabama (93)
Alaska (7)
Arizona (351)
Arkansas (14)
Asia (40334)
Australia (6592)
California (13421)
Canada (3805)
China (1370)
Colorado (570)
Connecticut (579)
Delaware (412)
Europe (87068)
Florida (2013)
Georgia (431)
Hawaii (3)
Idaho (62)
Illinois (1063)
India (91)
Indiana (604)
Iowa (23)
Japan (543)
Kansas (131)
Kentucky (50)
Louisiana (42)
Maine (76)
Maryland (1614)
Massachusetts (9580)
Michigan (366)
Minnesota (729)
Mississippi (6)
Missouri (145)
Montana (33)
Nebraska (30)
Nevada (143)
New Hampshire (84)
New Jersey (3518)
New Mexico (30)
New York (3504)
North Carolina (1724)
North Dakota (9)
Northern California (6739)
Ohio (402)
Oklahoma (23)
Oregon (41)
Pennsylvania (2692)
Puerto Rico (29)
Rhode Island (50)
South America (1133)
South Carolina (86)
South Dakota (2)
Southern California (5293)
Tennessee (214)
Texas (2135)
United States (47352)
Utah (402)
Vermont (1)
Virginia (327)
Washington D.C. (80)
Washington State (1071)
West Virginia (4)
Wisconsin (132)
Wyoming (2)
737,074 Results for "emergent biosolutions inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Emergent BioSolutions to Participate in Upcoming Investor Conferences - May 20, 2026
May 20, 2026
·
1 min read
Press Releases
Emergent BioSolutions Reports First Quarter 2026 Financial Results
April 30, 2026
·
35 min read
Press Releases
Emergent BioSolutions Participates in Upcoming International Preparedness Conferences
April 2, 2026
·
1 min read
Press Releases
Emergent BioSolutions Successfully Refinances Term Loan, Amends Asset-backed Loan Facility and Increases Financial Flexibility
April 17, 2026
·
4 min read
Press Releases
Emergent BioSolutions to Report First Quarter 2026 Financial Results on April 30, 2026
April 17, 2026
·
1 min read
Press Releases
Emergent BioSolutions Receives Saudi Food and Drug Authority Approval for ACAM2000® [Smallpox and Mpox (Vaccinia) Vaccine, Live]
May 18, 2026
·
5 min read
Press Releases
Emergent BioSolutions Receives Approval from Singapore Health Sciences Authority for Expanded Indication of ACAM2000® (Smallpox and Mpox (Vaccinia) Vaccine, Live) to Include Mpox
April 30, 2026
·
5 min read
Press Releases
Emergent BioSolutions and Substipharm Biologics Announce Strategic Manufacturing Partnership to Support Japanese Encephalitis Vaccine in the United States
April 28, 2026
·
5 min read
Press Releases
Emergent BioSolutions Announces New $50 Million Stock Repurchase Program
February 26, 2026
·
3 min read
Press Releases
Emergent BioSolutions Secures Long-Term Strategic Manufacturing Contract with SAB Biotherapeutics to Advance Type 1 Diabetes Candidate, SAB-142
April 29, 2026
·
4 min read
1 of 73,708
Next
